CADENCE PHARMA (CADX)

Overview Data Buy Sell Hold P&P Help

Quote Price $2.97 Price change for today in $ 0.02 Price change for today in % 0.68 Open Price $2.96 Previous Close $2.95 Daily Range $2.93 - $3.05 52-Week Range $2.72 - $10.00 Volume 194,040     Brokerage Analyst Recommendations  10 Brokerage Firms Covering CADX   Strong Buy 6 Buy 0 Hold 3 Sell 1 Strong Sell 0 Average Broker Recommendation (ABR):1.9    Description Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III products in development, including IV APAP, for the treatment of acute pain and fever, and Omigard for the prevention of catheter-related infections. The Company is committed to the fevelopment and commercialization of pharmaceuticals to meet the needs of hospitalized patients and their caregivers.   12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO, CA 92130, USA Phone: 8584361400 Fax: 858-436-1401 Web: http://www.cadencepharm.com Email: r@cadencepharm.com Industry:MED-DRUGS Sector: Medical Fiscal Year End:December Last Reported Quarter:03/31/12 Next EPS Date:08/08/12

Capital Structure Solvency and Cash Flow No comments yet. Be the first

Governance Social Responsibility and Employee Relations No comments yet. Be the first

Acquisitions Divestitures and Joint Ventures No comments yet. Be the first

Recent and Upcoming Events May 21, 2012 08:20 Biotech Industry Booming in 2012 May 11, 2012 17:00 Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The JMP Securities 11th Annual Research Conference In San Francisco On May 15, 2012 May 09, 2012 15:05 Shares of Cadence Pharmaceuticals Fall Below Previous 52-Week Low May 09, 2012 09:25 Cadence Pharmaceuticals Q1 net loss decreases May 07, 2012 15:08 Shares of Cadence Pharmaceuticals Fall to a New 52-Week Low May 04, 2012 20:56 Cadence Pharmaceuticals, Inc. (CADX) Corporate Event Announcement Notice May 04, 2012 15:05 Recent 52-Week Low Surpassed in Shares of Cadence Pharmaceuticals (CADX) May 04, 2012 11:15 Investors look to Lighten Up on Shares of Cadence Pharmaceuticals, Shares Down 12.0% (CADX) May 04, 2012 11:14 Investors look to Lighten Up on Shares of Cadence Pharmaceuticals, Shares Down 12.0% (CADX) May 03, 2012 20:56 Cadence Pharmaceuticals, Inc. (CADX) Corporate Event Announcement Notice May 03, 2012 16:00 Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results May 02, 2012 16:00 Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual Health Care Conference In Boston On May 8, 2012 Apr 25, 2012 20:52 Cadence Pharmaceuticals, Inc. (CADX) Corporate Event Announcement Notice Apr 24, 2012 21:32 Cadence Pharmaceuticals, Inc. (CADX) Corporate Event Announcement Notice Apr 24, 2012 20:52 Cadence Pharmaceuticals, Inc. (CADX) Corporate Event Announcement Notice

Major Risks No comments yet. Be the first

---

Created by: WikiMigrationBot. Last Modification: Thursday 03 of June, 2010 06:29:17 CDT by WikiMigrationBot.